Study of the Long-Term Safety of Pramlintide in Subjects With Type 1 Diabetes Mellitus

Clinical trial NCT00107107 · COMPLETED

Trial details

NCT number: NCT00107107
Sponsor: AstraZeneca
Status: COMPLETED
Phase: Phase 3
Study type: INTERVENTIONAL

Diabetes Mellitus, Type 1

Start date: 2002-11-01
Primary completion: 2005-06-01
Enrollment: 190

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.